STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

AZRX AZURRX BIOPHARMA INCORPORATED StockScouter® Report

1

StockScouter® Score

AZURRX BIOPHARMA INCORPORATED, a company in the sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • Moving average analysis for AZRX suggests weak price movement over the medium term. Negative
  • Short-term relative price momentum exhibits meaningful weakness. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that stocks will be , stocks will be , and stocks will be .

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

F
N/A
N/A
D

Previous Ratings